Roblox is an outdated platform unlikely to attract future generations. Click here to find out why I rate RBLX stock a Sell.

Many consumers treat Amazon AMZN as the go-to source for any number of goods and services. But unbeknownst to most of them, Amazon has been bringing its might to the world of business-oriented ...

Balanced investment portfolios are out of favor, but don’t count them out. The odds are good that a conservative 60% stock/40% bond portfolio will outperform the S&P 500 SPX over the next decade.

As the U.S. job market is reshaped by artificial intelligence and demographic changes, the nation’s largest private employer is trying to identify the skills its workers might need in the future, the ...

From its writing capabilities to its photo generation features, it’s no secret what a powerful tool artificial intelligence has become — both to the everyday person and employers. Some AI ads point ...

A new retail team specializing in tenant representation has joined SRS Real Estate Partners in Newport Beach. Jeff Straka, Debra Hoppe, and Hannah Rogers bring decades of retail real estate expertise ...

The Kroger Co. (NYSE:KR) may not get as much attention as high-growth technology names, but it stands as one of the largest grocery chains in the US, delivering steady earnings, rewarding shareholders ...

Scott Baird is a contributor with over a decade's experience writing about video games, along with board games and tabletop RPGs. Scott has previously worked for Dexerto, Cracked, Dorkly, and Gamepur.

Looking for great buys in the AI space? These companies have what it takes to be big winners. Artificial intelligence (AI) has played a big role in pushing the stock market to new highs, and there are ...

The social media company's stock saw its value climb by 11.63% in a week, a rally underscored by unprecedented trading activity. On Thursday, Sept. 18th, trading volume peaked at over 202 million ...

Forsaken is one of the most popular 1 vs all survival games on the Robloxplatform. And this is not surprising, since in addition to many characters, it can offer a wide range of customization. This ...

There are two FDA-approved medications for the metabolic disorder known as MASH. Roche is paying $2.4 billion to acquire 89bio and its late-stage MASH drug, giving the Swiss pharmaceutical giant the ...